Pharpoint Research Wins Project Award From Otologic Pharmaceuticals
8/18/2014 10:45:31 AM
DURHAM, N.C.--(BUSINESS WIRE)--North Carolina-based CRO, PharPoint Research, today announced their award from Otologic Pharmaceuticals for a full service, Phase I clinical trial assessing the safety, tolerability, and pharmacokinetic profile of agents in the treatment of hearing loss.
“Hearing loss is the third most common physical ailment behind arthritis and heart disease,” noted Audra McRae, PharPoint’s Chief Operating Officer. “Using our team’s experience we are excited to work on a product that potentially eases the troubles for those affected by hearing loss.”
Hey, check out all the research scientist jobs. Post your resume today!
comments powered by